Real-time enrollment status for this severe tricuspid regurgitation clinical trial
Current Status
Recruiting
Checked: September 26, 2026 at 6:05 AM UTC
| NCT Number | NCT07321899 |
| Recruiting Status | Recruiting |
| Condition | Severe Tricuspid Regurgitation |
| Phase | NA |
| Target Enrollment | 1,186 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Medtronic Cardiovascular |
| Last Updated on CT.gov | September 25, 2026 (Yesterday) |
As of September 26, 2026: Clinical trial NCT07321899 is currently recruiting participants. This na study for severe tricuspid regurgitation is actively seeking new participants at 13 locations across the United States. The study is sponsored by Medtronic Cardiovascular. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07321899 is actively recruiting participants as of September 26, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07321899 was last updated Yesterday (September 25, 2026). HelloStudys verifies this status automatically.